Aclidinium bromide/formoterol fumarate fixed-dose combination for the treatment of chronic obstructive pulmonary disease

Author： Cazzola Mario   Rogliani Paola   Matera Maria Gabriella  

Publisher： Informa Healthcare

ISSN： 1465-6566

Source： Expert Opinion on Pharmacotherapy, Vol.14, Iss.6, 2013-04, pp. : 775-781

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacokinetics of aclidinium bromide/formoterol fumarate fixed‐dose combination compared with individual components: A phase 1, open‐label, single‐dose study

By  

Clinical Pharmacology In Drug Development, Vol. 5, Iss. 2, 2016-03 ,pp. : 109-117

John Wiley & Sons Inc

Access to resources Recommend Favorite

Aclidinium bromide for the treatment of chronic obstructive pulmonary disease

By Cazzola Mario   Page Clive P   Matera Maria Gabriella  

Expert Opinion on Pharmacotherapy, Vol. 14, Iss. 9, 2013-06 ,pp. : 1205-1214

Informa Healthcare

Access to resources Recommend Favorite

Budesonide and formoterol combination for the treatment of chronic obstructive pulmonary disease

By Centanni Stefano   Di Marco Fabiano  

Expert Opinion on Pharmacotherapy, Vol. 6, Iss. 14, 2005-11 ,pp. : 2525-2534

Informa Healthcare

Access to resources Recommend Favorite

Aclidinium: In Chronic Obstructive Pulmonary Disease

By Frampton James E.  

Drugs, Vol. 72, Iss. 15, 2012-10 ,pp. : 1999-2011

Adis International

Access to resources Recommend Favorite

Formoterol Monotherapy Compared with Combined Ipratropium Bromide plus Fenoterol in the Treatment of Chronic Obstructive Pulmonary Disease

By Konermann M.  

Clinical Drug Investigation, Vol. 21, Iss. 4, 2001-04 ,pp. : 235-242

Adis International

Access to resources Recommend Favorite